tevatobramycin.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Teva’s Tobramycin Inhalation |
| Description | Teva offers an FDA-approved generic version of Bethkis® (Tobramycin Inhalation Learn about Teva’s FDA-approved Tobramycin Inhalation |
| Keywords | teva generic tobramycin, generic tobramycin, equivalent to Bethkis, FDA-approved generic tobramycin, Teva’s Tobramycin Inhalation Solution, Bethkis generics, cystic fibrosis treatment |
Server Information
| WebSite | |
| Host IP | 45.60.152.158 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tevatobramycin.com Valuation
|
US$1,061
Last updated: 2023-05-19 23:34:56
tevatobramycin.com has Semrush global rank of 0. tevatobramycin.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. tevatobramycin.com receives approximately 122 unique visitors each day. Its web server is located in United States, with IP address 45.60.152.158. According to SiteAdvisor, tevatobramycin.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,061 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$29 |
| Yearly Ads Revenue | US$352 |
| Daily Unique Visitors | 8 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tevatobramycin.com. | A | 7198 | IP: 45.60.152.158 |
| tevatobramycin.com. | A | 7198 | IP: 45.60.172.158 |
| tevatobramycin.com. | NS | 86400 | NS Record: ns3.tevapharm.com. |
| tevatobramycin.com. | NS | 86400 | NS Record: ns4.tevapharm.com. |
| tevatobramycin.com. | NS | 86400 | NS Record: ns5.tevapharm.com. |
| tevatobramycin.com. | TXT | 86400 | TXT Record: v=spf1 -all |
| tevatobramycin.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=gm96fp57U2dLlHIhJQHvUc-7RxeN5NCRdu3gBRAke2 |
HtmlToTextCheckTime:2023-05-19 23:34:56
| Full Prescribing Information Teva’s Tobramycin Inhalation Solution Savings & Access When and How to Use FAQ Savings Card For the management of cystic fibrosis with Pseudomonas aeruginosa. Teva offers an FDA-approved generic version of Bethkis® (Tobramycin Inhalation Solution). Savings & Access Pay as little as $0* Download Savings Card * Eligibility requirements apply. Learn how to use Teva’s Tobramycin Inhalation Solution. Visit the When and How to Use Section Teva knows generics— it’s what we do. Find out how Teva became the leading producer of generics. More Show More Close IMPORTANT SAFETY INFORMATION Do not take tobramycin inhalation solution if you are allergic to tobramycin, any of the ingredients in tobramycin inhalation solution, or to any other aminoglycoside antibacterial. See the end of the Patient Information Leaflet found in the Prescribing Information for a complete list of ingredients in tobramycin inhalation solution. Before you take tobramycin inhalation solution, |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://www.tevatobramycin.com/
Content-Length: 0
Connection: close
HTTP/2 200
content-length: 28708
content-type: text/html; charset=utf-8
date: Sat, 10 Dec 2022 09:09:19 GMT
server: Microsoft-IIS/10.0
access-control-expose-headers: Request-Context
cache-control: no-cache
expires: -1
pragma: no-cache
set-cookie: ASP.NET_SessionId=wzdz1ozzqrkuq3deqjouy2x2; path=/; HttpOnly; SameSite=Lax
set-cookie: EPi_NumberOfVisits=1,2022-12-10T09:09:20; expires=Sun, 10-Dec-2023 09:09:20 GMT; path=/
set-cookie: Epinephrine_Website_HCC={"cookie_id":"Epinephrine_Website_HCC_12102022090920","HasLoggedIn":false,"Expire":"\/Date(1686215360419)\/","activities":null}; expires=Thu, 08-Jun-2023 09:09:20 GMT; path=/
x-aspnetmvc-version: 5.2
x-aspnet-version: 4.0.30319
request-context: appId=cid-v1:71b15f06-b686-465a-bcf2-5cf231669cde
x-powered-by: ASP.NET
arr-disable-session-affinity: true
x-frame-options: DENY
set-cookie: visid_incap_2388856=wiSvAzLkQb+l4Do7HGdRzL9MlGMAAAAAQUIPAAAAAABv+vVnw1XiE5akWXhQ8Mzc; expires=Sat, 09 Dec 2023 22:14:50 GMT; HttpOnly; path=/; Domain=.tevatobramycin.com
set-cookie: nlbi_2388856=QDnKJvNlsy6/OQr1EaBZlAAAAAANdnjkSPNIEQ6cukguOkGN; path=/; Domain=.tevatobramycin.com
set-cookie: incap_ses_1609_2388856=pyZPF3uRMkP629qvI1FUFsBMlGMAAAAAwCnBhYLc/AKMWLLnJ7viKA==; path=/; Domain=.tevatobramycin.com
x-cdn: Imperva
x-iinfo: 15-279897469-279897475 NNNN CT(103 210 0) RT(1670663359651 32) q(0 0 3 0) r(7 7) U6
|
tevatobramycin.com Whois Information
Domain Name: TEVATOBRAMYCIN.COM Registry Domain ID: 2536793079_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2022-06-07T23:14:30Z Creation Date: 2020-06-12T13:07:52Z Registry Expiry Date: 2023-06-12T13:07:52Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS3.TEVAPHARM.COM Name Server: NS4.TEVAPHARM.COM Name Server: NS5.TEVAPHARM.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-10T08:50:13Z <<< |